Recent Patents on DNA & Gene Sequences (DIscontinued)

Christian Bronner  
Institute of Genetics and Molecular and Cellular Biology
University of Strasboug
France

Back

Recent Patents Related to Phosphorylation Signaling Pathway on Cancer

Author(s): Karina B. Acosta, Maria M. Tibolla, Maria M. Tiscornia, Maria A. Lorenzati, Pedro D. Zapata.

Abstract:

Phosphorylation and dephosphorylation play an important role in the regulation of growth factor and cytokine signal transduction to modulate cell proliferation, differentiation, survival, and apoptosis. In some cellular systems, the information suggests that EGFR, somatostatin receptors, SHP-1, Akt and PI3K can regulate carcinogenesis implied process through regulated the activity of NF-κB. Current patents related to signaling pathway that includes somatostatin receptors, phosphotyrosine phosphatases, tyrosine kinases, AKT/PKB and PI3K are focusing in diagnosis, prognosis and treatment. Many recent patented techniques include inhibition, antagonism or alternative therapeutic methods. Furthermore, it is necessary to deepen understanding of the molecular mechanisms involved in cancer to develop other alternative therapies focusing not only on new inhibitors.

Keywords: Phosphotyrosine kinases, phosphotyrosine phosphatases, signaling pathway, diagnosis, treatment, cancer, PDGF receptor, EGF receptor, VEGF receptor, mTorC1, DNA-PK, Akt, Duals PTP, Non Receptor Classic PTP, Receptor Classic PTP, SSTR2 / SHP-1, cleavable marker, retinal blindness

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

VOLUME: 5
ISSUE: 3
Year: 2011
Page: [175 - 184]
Pages: 10
DOI: 10.2174/187221511797636257
Price: $100